NPPB and hydrops fetalis: In the PARAMOUNT (Prospective Comparison of ARN Inhibitors with ARB on Management of HF With Preserved Ejection Fraction) phase II trial, NT-proBNP was significantly reduced at 12 weeks with LCZ696 (sacubitril-valsartan) treatment compared with valsartan.65